Latest Announcements

S.J.S. Enterprises Ltd has informed the Exchange about attending a 17th Annual Investor Conference, India Xchange 2026 organized by JM Financial, on 17th Nov 2026 in Mumbai from 12:00 PM (IST) onwards.

Alembic Pharmaceuticals Limited held an earnings conference call for Q2 and H1 FY27, with a consolidated revenue growth of 36% Y-on-Y. The company's India business delivered a 14% year-on-year growth, driven by strong performances in Human Health and Animal Health. The U.S. Generics business showed exceptional growth with revenue increasing by 72% year-on-year. The company also announced an expansion of its strategic collaboration with DifGen Pharmaceuticals, giving access to a differentiated portfolio of over 20 products.

Ind-Swift Laboratories Ltd has announced its Q2 FY27 earnings, with a 50.15% year-on-year increase in operating revenue to ₹234.89 crore. The company's operating EBITDA rose 4.95x year-on-year to ₹42.33 crore, and the operating EBITDA margin expanded 1,256 basis points to 18.02%. The PAT surged 3.54x year-on-year to ₹31.03 crore, delivering a PAT margin of 13.21%. The company's H1 FY27 performance also saw a 35.79% year-on-year increase in operating revenue to ₹420.97 crore, with operating EBITDA surging 4.45 times to ₹75.65 crore and EBITDA margin expanding by 1,254 basis points to 17.97%. The company's export footprint remains the primary growth engine, with 82.7% of total sales, while domestic verticals continue to provide steady cash flow stability with 17.3% of total sales.

Ind-Swift Laboratories Limited has informed the Exchange about the transcript of the Conference Call held on Wednesday, November 04, 2026, with Analysts/Investors to discuss the Un-audited Financial Results of the Company for the quarter ended September 30, 2026 (Q2 FY27).

Covance Softsol Ltd approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee.

Inventurus Knowledge Solutions Ltd has acquired 100% of Turbo Health Holdings, LLC for USD 500,000. The acquisition is in the healthcare technology and IT services/software industry. The acquisition is expected to strengthen the company's solutions and deliver greater value to its clients.

S.J.S. Enterprises Limited has informed the Exchange about attending a 17th Annual Investor Conference, India Xchange 2026 organized by JM Financial, on 17th Nov 2026 in Mumbai from 12:00 PM (IST) onwards.

Inventurus Knowledge Solutions Limited has informed the Exchange about Acquisition of Turbo Health Holdings, LLC. The acquisition represents an important opportunity to expand organisation's market reach. The complementary capabilities, expertise, and relationships will strengthen organisation's solutions and deliver greater value to healthcare organizations and clients it serves.

Vision Cinemas Ltd has announced its unaudited financial results for the quarter and half year ended September 30, 2026. The company's standalone and consolidated financial results have been approved by the Board of Directors. The results are accompanied by a limited review report from the statutory auditors. The review report notes that nothing has come to their attention that causes them to believe that the financial results have not disclosed the information required to be disclosed under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. However, the report draws attention to a non-compliance regarding the disclosure of the impact of pending litigations on the company's financial position.

Redington Limited has announced its Q2 FY 2026-27 earnings conference call transcript, with consolidated revenue reaching INR43,002 crores, a 48% year-on-year growth, and profit after tax excluding exceptional items rising 50% to INR581 crores.

Global Health Ltd has announced a schedule for an institutional investor meet, to be held on November 19 and 20, 2026, with various asset management firms and investment companies. The meeting will be held in person and will not involve the sharing of unpublished price sensitive information.

Covance Softsol Ltd approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee.

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about the schedule of an investor/analysts meet on November 16, 2026, at Grand Hyatt, Mumbai.

Global Health Ltd has announced a schedule for an institutional investor meet, to be held on November 19 and 20, 2026, with various asset management firms and investment companies. The meeting will be held in person and will not involve the sharing of unpublished price sensitive information.

Acme Resources Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/11/2026 to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the Second Quarter (Q2) and Half Year of FY 2026-27, ending on September 30, 2026.

Redington Ltd, a company in the technology sector, has announced its Q2 FY27 earnings, with consolidated revenue reaching INR43,002 crores, a 48% year-on-year growth, and profit after tax, excluding exceptional items, rising 50% to INR581 crores. The company's performance is attributed to its resilient portfolio, designed for growth, scale, and relevance, with growth remaining broad and the core business converting that growth into stronger earnings.

IIFL Finance Ltd has informed the Exchanges regarding Subscription Agreements entered into by the Company. The Board of Directors has approved the increase in authorised share capital, issuance of compulsorily convertible preference shares and warrants, and alteration of capital clause of the Memorandum of Association.

TVS Supply Chain Solutions Ltd has scheduled an earnings call with analysts/investors to discuss unaudited financial results for the quarter and half year ended September 30, 2026.

Delhivery Ltd has informed the Exchanges about a Schedule of Investors' Conference, to be held on November 17, 2026, in Singapore. The meeting will discuss general business outlook and information already in the public domain.

M P K Steels (I) Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 13/11/2026 to consider and approve the Un-audited Financial Results for the quarter and half year ended on September 30, 2026.